Growth at Reasonable Price
Resultat
7
2 ny
7 Företag
| Företag | Senaste pris | 7D Återkomst | 1 års avkastning | Marknadsvärde | Analytikernas mål | Värdering | Tillväxt | Avkastning på aktier | Industri | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
DOV | €1.80 | -9.2% | -35.6% | €342.1m | €2.70 | 0.6 | 86.4% | 5.1% | Commercial Services | ||
EGLA Ny | €1.00 | -2.3% | -72.5% | €162.7m | €1.19 | 0.2 | 108.4% | 4.2% | Capital Goods | ||
FCT | €12.91 | 4.0% | -31.2% | €4.6b | €17.78 | 24.2 | 27.7% | 0% | Capital Goods | ||
SES Ny | €93.40 | 2.6% | 30.1% | €1.4b | €118.80 | 19.7 | 15.1% | 1.4% | Tech | ||
FF | €8.72 | 1.9% | 0.2% | €205.1m | €13.06 | 29.8 | 32.3% | 1.8% | Pharmaceuticals & Biotech | ||
MFEB | €3.61 | -1.3% | -10.6% | €2.1b | €4.13 | 11.3 | 22.5% | 6.1% | Media | ||
REC | €52.65 | -0.8% | -0.7% | €10.8b | €59.26 | 21.7 | 15.2% | 2.5% | Pharmaceuticals & Biotech |
Page 1 of 1